Clinical Trial Update: D-cycloserine Augmented CBT for Panic Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating D-cycloserine as an adjunct to cognitive-behavioral therapy for Panic Disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Oxford | Conditions: Panic Disorder | Phase 3 | Status: TERMINATED